Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
Public ClinicalTrials.gov record NCT00498628. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Placebo Controlled Trial to Assess the Efficacy of Quetiapine Fumarate Extended Release for the Treatment of Alcohol Dependence in Very Heavy Drinkers.
Study identification
- NCT ID
- NCT00498628
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- NIH
- Enrollment
- 224 participants
Conditions and interventions
Conditions
Interventions
- Quetiapine fumarate Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2007
- Primary completion
- Jul 31, 2009
- Completion
- Feb 28, 2010
- Last update posted
- Mar 18, 2019
2007 – 2010
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Boston University School of Medicine, Psychiatry Clinical Studies Unit | Boston | Massachusetts | 02118 | — |
| Dartmouth Medical School, Dept. of Psychiatry | Lebanon | New Hampshire | 03755 | — |
| University of Pennsylvania, Treatment Research Center | Philadelphia | Pennsylvania | 19104 | — |
| Brown University Center for Alcohol and Addiction Studies | Providence | Rhode Island | 12906 | — |
| White River Junction VA Medical Center | White River Junction | Vermont | 05009 | — |
| University of Virginia, Dept. of Psychiatric Medicine | Charlottesville | Virginia | 22908 | — |
| University of Virginia | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00498628, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00498628 live on ClinicalTrials.gov.